Treatment of diffuse in-scent restenosis with rotational atherectomy followed by radiation therapy with a rhenium-188-mercaptoacetyltriglycine-filledballoon
Sw. Park et al., Treatment of diffuse in-scent restenosis with rotational atherectomy followed by radiation therapy with a rhenium-188-mercaptoacetyltriglycine-filledballoon, J AM COL C, 38(3), 2001, pp. 631-637
Citations number
23
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
OBJECTIVES This study was done to evaluate the feasibility and efficacy of
beta-radiation therapy with a rhenium-188-mercaptoacetyltriglycine (Re-188-
MAG(3))-filled balloon after rotational atherectomy for diffuse in-stent re
stenosis (ISR).
BACKGROUND Rotational atherectomy has been shown to be safe and efficient f
or the treatment of ISR, but the recurrence rate is still high. Intracorona
ry beta-irradiation after rotational atherectomy may be a reasonable approa
ch to prevent recurrent ISR.
METHODS Fifty consecutive patients with diffuse ISR (length > 10 mm) in nat
ive coronary arteries underwent rotational atherectomy and adjunctive ballo
on angioplasty, followed by beta-irradiation using a Re-188-MAG(3) filled b
alloon catheter. The radiation dose was 15 Gy at a depth of 1.0 mm into the
vessel wall.
RESULTS The mean lengths of the lesion and irradiated segment were 25.6 +/-
12.7 mm and 37.6 +/- 11.2 mm, respectively. Radiation was delivered succes
sfully to all patients, with a mean irradiation time of 201.8 +/- 61.7 s. N
o adverse event, including myocardial infarction, death or stent thrombosis
, occurred during the follow-up period (mean 10.3 +/- 3.7 months), and nont
arget vessel revascularization was needed in one patient. The six-month bin
ary angiographic restenosis rate was 10.4%, and the loss index was 0.17 +/-
0.31.
CONCLUSIONS Beta-irradiation using Re-188-MAG(3) filled balloon after rotat
ional atherectomy is safe and feasible in patients with diffuse ISR, and it
may improve their clinical and angiographic outcomes. Further prospective,
randomized trials are warranted to evaluate the synergistic effect of debu
lking and irradiation in patients with diffuse ISR. (C) 2001 by the America
n College of Cardiology.